Lyphochek Diabetes Control
FDA 510(k) K070546 · Bio-Rad Laboratories
510(k) numberK070546
Submission
- Device name
- Lyphochek Diabetes Control
- Applicant
- Bio-Rad Laboratories
Irvine, CA, US - Received
- February 26, 2007
- Decision date
- April 2, 2007
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- GGM – Control, Hemoglobin
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 864.8625
- Specialty
- Hematology
Other 510(k)s with product code GGM
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K192842 | HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo HighGGM · Traditional | Eurotrol B.V. | 11/15/2019SE |
| K182744 | HemoTrol WB - Low, HemoTrol WB - Normal, HemoTrol WB - HighGGM · Traditional | Eurotrol B.V. | 02/01/2019SE |
| K070334 | R&D Sickle QC ControlGGM · Traditional | R&D Systems, Inc. | 03/29/2007SE |
| K052838 | Liquichek Diabetes Control, Level 1,2,3,4GGM · Traditional | Bio-Rad | 11/09/2005SE |
| K032791 | Glycohemosure HBA1C ControlGGM · Traditional | Quantimetrix Corp. | 10/30/2003SE |
| K003030 | Lyphochek Hemoglobin Alc Linearity SetGGM · Traditional | Bio-Rad | 11/29/2000SE |
| K993321 | R&D Hgb/Glc Whole Blood ControlGGM · Traditional | R&D Systems, Inc. | 11/12/1999SE |
| K964052 | Hemocue HemotrolGGM · Traditional | Direct Solutions | 11/06/1996SE |
| K963908 | Hemocue HemolinGGM · Traditional | Direct Solutions | 10/16/1996SE |
| K921681 | Criterion, Hemocue B-Hemoglobin ControlGGM · Traditional | Isolab, Inc. | 11/17/1992SE |
More from Isolab, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K183446 | BioPlex 2200 Lyme TotalLSR · Traditional | 03/12/2019SE |
| K181661 | QXDx BCR-ABL %IS Kit for use on the QXDx AutoDG ddPCR SystemOYX · Traditional | 02/13/2019SE |
| K180577 | BioPlex 2200 25-OH Vitamin D KitMRG · Traditional | 06/22/2018SE |
| K171664 | Hemoglobin Variants System on Newborn Hemoglobin System with GDM and HbReview SoftwareGKA · Special | 09/13/2017SE |
| K170509 | BioPlex 2200 ToRC IgM, BioPlex 2200 ToRC IgM Calibrator Set, BioPlex 2200 ToRC IgM…PUQ · Traditional | 05/19/2017SE |
| K170413 | BioPlex 2200 Syphilis Total & RPR, BioPlex 2200 Syphilis Total & RPR Calibrator Set…LIP · Traditional | 05/11/2017SE |
| K163015 | Liquichek Tumor Marker Control-Level 1; Liquichek Tumor Marker Control-Level 2…JJY · Traditional | 01/10/2017SE |
| K161687 | D-10 Hemoglobin A1c ProgramPDJ · Traditional | 10/14/2016SE |
| K152679 | Amplichek I, Negative , Amplichek I, Level 1, Amplichek I, Level 2, Amplichek I, Level…PMN · Traditional | 05/10/2016SE |
| K150300 | Liquichek Cardiac Markers Plus Control LTJJY · Traditional | 12/11/2015SE |
Questions and answers
When was Lyphochek Diabetes Control cleared by the FDA?
Lyphochek Diabetes Control (K070546) received a 510(k) decision of Substantially Equivalent on April 2, 2007, 35 days after the submission was received.
What is the product code of K070546?
The FDA product code is GGM – Control, Hemoglobin, a Class II (moderate risk) device regulated under 21 CFR 864.8625.